Tourmaline Bio, Inc. NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to ...

CALGARY, AB, May 7, 2025 /CNW/ - Tourmaline Oil Corp. (TSX: TOU) ("Tourmaline" or the "Company") is pleased to release financial and operating results for the first quarter of 2025, announce two ...

You can reach Adam on Signal at stataf.54. Tourmaline Bio said Tuesday that its experimental antibody treatment demonstrated deep reductions in a measure of inflammation often tied to heart ...

The TRANQUILITY trial is the starting point of Tourmaline’s clinical development program for pacibekitug for the potential treatment of atherosclerotic cardiovascular disease (ASCVD) and other ...

Tourmaline will host a conference call tomorrow, May 8, 2025, starting at 9:00 a.m. MT (11:00 a.m. ET). To participate without operator assistance, you may register and enter your phone number at ...

Tourmaline Bio’s lead candidate sparkled in a mid-stage data drop, prepping the biotech to develop the former Pfizer asset further in a pair of cardiovascular indications. Pacibekitug, an ...

Investing.com -- Tourmaline Bio, Inc. (NASDAQ: TRML) stock fell 3% after the company announced positive topline results from the Phase 2 TRANQUILITY trial evaluating pacibekitug in patients with ...

Explore all key property features for Lot 667 Tourmaline Boulevard, Madora Bay. Click here to find out more. What is the size of the property at Lot 667 Tourmaline Boulevard, Madora Bay?

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve ...

In other recent news, Tourmaline Bio has reported its fourth-quarter and full-year financial results for 2024, with a net loss of $22.2 million, or ($0.86) per share, slightly exceeding the ...

In trading on Tuesday, shares of Tourmaline Oil Corp (TSX: TOU.TO) crossed above their 200 day moving average of $63.91, changing hands as high as $64.54 per share. Tourmaline Oil Corp shares are ...

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the ...